DIVISLABPharmaceuticals
Divis Laboratories Ltd — PE Ratio & Valuation Analysis
₹5947.00
-1.42%
Current P/E68.59xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E66.5x3.1% above avg
⚠️
115.9% Premium to Industry
DIVISLAB P/E 68.59x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹82.53 | ₹6393 | 77.5x |
| 2024 | ₹60.27 | ₹6099 | 101.2x |
| 2023 | ₹68.69 | ₹3904 | 56.8x |
| 2022 | ₹111.52 | ₹3413 | 30.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Divis Laboratories Ltd Valuation
Divis Laboratories Ltd (DIVISLAB) currently trades at 68.59x earnings. The Pharmaceuticals sector average PE is 31.77x. DIVISLAB commands a premium, reflecting high growth expectations. Historically, DIVISLAB has traded at an average PE of 66.5x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
15.35%
Dividend Yield
0.47%
More on Divis Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.